Expression of HRI was previously thought to be restricted to erythroid cells [36], however, recent findings suggest that HRI may be expressed more broadly, including in some hematologic malignancies such as MM and Ph+ B-cell ALL (B-ALL), where HRI activity has been implicated in the regulation of apoptosis [39, 40]. This evidence concerns the gene EIF2AK1 and acute lymphoblastic leukemia.